TC BioPharm (Holdings) PLC (TCBP)
0.6239
-0.01
(-0.94%)
USD |
NASDAQ |
Nov 22, 16:00
0.6199
0.00 (0.00%)
After-Hours: 20:00
TC BioPharm Cash from Investing (Quarterly): -0.0071M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -0.0071M |
| June 30, 2023 | -0.0949M |
| March 31, 2023 | -0.1765M |
| Date | Value |
|---|---|
| September 30, 2021 | -0.1257M |
| September 30, 2020 | -0.1964M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-0.1964M
Minimum
Sep 2020
-0.0071M
Maximum
Mar 2024
-0.1201M
Average
-0.1257M
Median
Sep 2021
Cash from Investing (Quarterly) Benchmarks
| Adaptimmune Therapeutics PLC | -66.02M |
| Biodexa Pharmaceuticals PLC | -- |
| Verona Pharma PLC | 0.00 |
| NuCana PLC | -0.0053M |
| Autolus Therapeutics PLC | -9.589M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -3.055M |
| Cash from Financing (Quarterly) | 1.183M |
| Free Cash Flow | -15.84M |
| Free Cash Flow Per Share (Quarterly) | -20.32 |
| Free Cash Flow Yield | -54.16K% |